Keyword: Watson

News

Novo Nordisk Invests in UK Research Center

01.02.2017 - Novo Nordisk has announced plans to invest 1 billion Danish kroner ($145 million) over 10 years in a new research center at the University of Oxford, giving a major boost to the UK...

News

Pfizer and IBM in e-Health Alliance

19.12.2016 - Major US drugmaker Pfizer will use IBM Watson Health’s artificial intelligence technology to help in its efforts to find new cancer medicines. The deal will use the Watson for Drug...

News

The Biosimilar Market

07.02.2014 - Pharmaceuticals - Many biologic drug developers can be pleased with how well their products have performed in the market place. Blockbuster products such as Abbvie's (ex-Abbott)...

News

Merger of Drugmakers Valeant, Actavis on Hold

28.04.2013 - A proposed merger of Valeant Pharmaceuticals International and Actavis was put on hold after the two drugmakers failed to agree on terms of a deal that would have created a...

News

Actavis to Sell Generic Yaz Birth Control After Ruling

17.04.2013 - Pharmaceutical company Actavis said on Tuesday that it would once again sell a generic version of Bayer's Yaz after an appeals court ruled that Bayer's patent for the oral...

News

Top U.S. Court to Decide on Deals to Delay Cheaper Drugs

23.03.2013 - The U.S. Supreme Court will hear arguments on Monday over whether big drug companies can settle patent litigation with generic rivals by making deals to keep cheaper products off...

News

Pfizer Gets Celebrex Patent Extension

05.03.2013 - U.S. regulators granted Pfizer a reissued patent on its multibillion-dollar Celebrex pain drug that extends its marketing exclusivity until early December 2015, the company said on...

News

Actavis, Formerly Watson, Sees 2013 Profit Growth

25.01.2013 - Actavis, the generic drugmaker previously known as Watson Pharmaceuticals, said on Friday that it expected earnings to rise at least 30% in 2013 as it expands globally, but its...